Omnicare To Pay $50M To Settle DEA's Rx Misconduct Claims

Law360, New York (May 11, 2012, 4:38 PM EDT) -- Nursing-home pharmacy firm Omnicare Inc. said Friday it has been fined $50 million for doling out controlled substances without proper prescriptions, misconduct the company suggested resulted from a murky understanding of the law.

The settlement stemmed from a U.S. Drug Enforcement Administration investigation that found Omnicare routinely dispensed drugs to residents of long-term care centers without signed prescriptions and distributed pharmaceuticals in emergencies without oral prescriptions.

Instead, Omnicare frequently accepted medical chart orders and oral directives from nursing home staff as reasonable substitutes, DEA officials said....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.